Thanat Kanthawang, Wanat Wudhikulprapan, Phichayut Phinyo, Jongkolnee Settakorn, Dumnoensun Pruksakorn, Thomas M Link, Nuttaya Pattamapaspong
{"title":"常规磁共振成像能否预测骨肉瘤的化疗耐药性？","authors":"Thanat Kanthawang, Wanat Wudhikulprapan, Phichayut Phinyo, Jongkolnee Settakorn, Dumnoensun Pruksakorn, Thomas M Link, Nuttaya Pattamapaspong","doi":"10.1093/bjr/tqad047","DOIUrl":null,"url":null,"abstract":"Histological tumour necrosis is the current indicator for the response of osteosarcoma after neoadjuvant chemotherapy. Chemoresistant tumours require close monitoring and adjustment of treatment. Characteristics of tumours on baseline MRI may be able to predict response to chemotherapy. The aim is to identify which baseline MRI findings can help predict chemoresistant osteosarcoma.","PeriodicalId":516851,"journal":{"name":"The British Journal of Radiology","volume":"8 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-02-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Can conventional magnetic resonance imaging at presentation predict chemoresistance in osteosarcoma?\",\"authors\":\"Thanat Kanthawang, Wanat Wudhikulprapan, Phichayut Phinyo, Jongkolnee Settakorn, Dumnoensun Pruksakorn, Thomas M Link, Nuttaya Pattamapaspong\",\"doi\":\"10.1093/bjr/tqad047\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Histological tumour necrosis is the current indicator for the response of osteosarcoma after neoadjuvant chemotherapy. Chemoresistant tumours require close monitoring and adjustment of treatment. Characteristics of tumours on baseline MRI may be able to predict response to chemotherapy. The aim is to identify which baseline MRI findings can help predict chemoresistant osteosarcoma.\",\"PeriodicalId\":516851,\"journal\":{\"name\":\"The British Journal of Radiology\",\"volume\":\"8 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-02-03\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The British Journal of Radiology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1093/bjr/tqad047\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The British Journal of Radiology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/bjr/tqad047","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Can conventional magnetic resonance imaging at presentation predict chemoresistance in osteosarcoma?
Histological tumour necrosis is the current indicator for the response of osteosarcoma after neoadjuvant chemotherapy. Chemoresistant tumours require close monitoring and adjustment of treatment. Characteristics of tumours on baseline MRI may be able to predict response to chemotherapy. The aim is to identify which baseline MRI findings can help predict chemoresistant osteosarcoma.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
